Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Maraviroc Compassionate Use.

Trial Profile

Maraviroc Compassionate Use.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 06 May 2016

At a glance

  • Drugs Maraviroc (Primary) ; Antiretrovirals
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Sponsors Pfizer; ViiV Healthcare
  • Most Recent Events

    • 10 Nov 2010 ViiV Healthcare added in associations field as reported by ClinicalTrials.gov.
    • 10 Nov 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 10 Nov 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top